These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 2705794

  • 1. Value of selective screening for congenital adrenal hyperplasia in Hungary.
    Sólyom J, Hughes IA.
    Arch Dis Child; 1989 Mar; 64(3):338-42. PubMed ID: 2705794
    [Abstract] [Full Text] [Related]

  • 2. [Screening for congenital adrenal hyperplasia in Hungary].
    Sólyom J.
    Orv Hetil; 1989 Sep 10; 130(37):1979-82, 1985-6. PubMed ID: 2780047
    [Abstract] [Full Text] [Related]

  • 3. Screening for congenital adrenal hyperplasia: distribution of 17 alpha-hydroxyprogesterone concentrations in neonatal blood spot specimens.
    Thompson R, Seargeant L, Winter JS.
    J Pediatr; 1989 Mar 10; 114(3):400-4. PubMed ID: 2784166
    [Abstract] [Full Text] [Related]

  • 4. [Identification of congenital adrenal hyperplasia by measurement of blood-spot 17-hydroxyprogesterone].
    Sólyom J, Eckhardt G, Török D.
    Orv Hetil; 2004 Oct 03; 145(40):2051-6. PubMed ID: 15559532
    [Abstract] [Full Text] [Related]

  • 5. Neonatal screening for congenital adrenal hyperplasia using 17-hydroxyprogesterone assay in filter paper blood spots.
    Larsson A, Hagenfeldt L, von Döbeln U, Curstedt T, Gustafsson J, Svensson E.
    Horm Res; 1988 Oct 03; 30(6):235-40. PubMed ID: 3250925
    [Abstract] [Full Text] [Related]

  • 6. Analysis of blood spot 17 alpha-hydroxyprogesterone concentration in premature infants--proposal for cut-off limits in screening for congenital adrenal hyperplasia.
    Ohkubo S, Shimozawa K, Matsumoto M, Kitagawa T.
    Acta Paediatr Jpn; 1992 Apr 03; 34(2):126-33. PubMed ID: 1621517
    [Abstract] [Full Text] [Related]

  • 7. Neonatal screening for congenital adrenal hyperplasia.
    Cacciari E, Balsamo A, Cassio A, Piazzi S, Bernardi F, Salardi S, Cicognani A, Pirazzoli P, Zappulla F, Capelli M.
    Arch Dis Child; 1983 Oct 03; 58(10):803-6. PubMed ID: 6639129
    [Abstract] [Full Text] [Related]

  • 8. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S.
    Pediatrics; 1988 Jun 03; 81(6):866-74. PubMed ID: 3259306
    [Abstract] [Full Text] [Related]

  • 9. Estimation of 17 alpha-hydroxyprogesterone in dried blood spots for mass screening of newborn infants with congenital adrenal hyperplasia.
    Mardesić D, Dumić M, Tajić M, Gjurić G, Letica-Protega N.
    Acta Med Iugosl; 1983 Jun 03; 37(2):95-100. PubMed ID: 6880831
    [No Abstract] [Full Text] [Related]

  • 10. Congenital adrenal hyperplasia: neonatal mass screening compared with clinical diagnosis only in the Emilia-Romagna region of Italy, 1980-1995.
    Balsamo A, Cacciari E, Piazzi S, Cassio A, Bozza D, Pirazzoli P, Zappulla F.
    Pediatrics; 1996 Sep 03; 98(3 Pt 1):362-7. PubMed ID: 8784357
    [Abstract] [Full Text] [Related]

  • 11. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 1. Enzyme immunoassay of dried blood 17 alpha-hydroxyprogesterone and its application to neonatal screening for congenital adrenal hyperplasia].
    Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N.
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun 20; 62(6):683-96. PubMed ID: 3530828
    [Abstract] [Full Text] [Related]

  • 12. Diurnal variation in blood 17-hydroxyprogesterone concentrations in untreated congenital adrenal hyperplasia.
    Sólyom J.
    Arch Dis Child; 1984 Aug 20; 59(8):743-7. PubMed ID: 6541026
    [Abstract] [Full Text] [Related]

  • 13. Twenty years experience in rapid identification of congenital adrenal hyperplasia in Hungary.
    Török D, Eckhardt G, Sólyom J.
    Eur J Pediatr; 2003 Dec 20; 162(12):844-9. PubMed ID: 14648216
    [Abstract] [Full Text] [Related]

  • 14. Bloodspot 17 alpha-hydroxyprogesterone radioimmunoassay for diagnosis of congenital adrenal hyperplasia and home monitoring of corticosteroid replacement therapy.
    Riordan FA, Wood PJ, Wakelin K, Betts P, Clayton BE.
    Lancet; 1984 Mar 31; 1(8379):708-11. PubMed ID: 6143043
    [Abstract] [Full Text] [Related]

  • 15. Screening for congenital adrenal hyperplasia: the Delfia Screening Test overestimates serum 17-hydroxyprogesterone in preterm infants.
    al Saedi S, Dean H, Dent W, Stockl E, Cronin C.
    Pediatrics; 1996 Jan 31; 97(1):100-2. PubMed ID: 8545200
    [Abstract] [Full Text] [Related]

  • 16. [The importance of 17-hydroxyprogesterone determination in the diagnosis and treatment of congenital adrenal hyperplasia].
    Banićević M, Subotić Z, Joksimović I.
    Srp Arh Celok Lek; 1982 Sep 31; 110(9):1025-34. PubMed ID: 7182937
    [No Abstract] [Full Text] [Related]

  • 17. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia.
    Robinson JA, Dyas J, Hughes IA, Riad-Fahmy D.
    Ann Clin Biochem; 1987 Jan 31; 24 ( Pt 1)():58-65. PubMed ID: 3827186
    [Abstract] [Full Text] [Related]

  • 18. Blood-spot 17-hydroxyprogesterone daily profiles in infants with congenital adrenal hyperplasia.
    Sólyom J, Hosszu E, Gács G.
    Exp Clin Endocrinol; 1990 Sep 31; 96(1):52-6. PubMed ID: 2279525
    [Abstract] [Full Text] [Related]

  • 19. Identification of enzyme deficiencies resulting in congenital adrenal hyperplasia.
    Sólyom J.
    Acta Biomed Ateneo Parmense; 1995 Sep 31; 66(3-4):99-104. PubMed ID: 8578942
    [Abstract] [Full Text] [Related]

  • 20. Clinical aspects of congenital adrenal hyperplasia: early diagnosis and prognosis.
    Hughes IA.
    J Inherit Metab Dis; 1986 Sep 31; 9 Suppl 1():115-23. PubMed ID: 3097410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.